Table of contents
June 2007, Volume 25 No 6 pp603-692
- In This Issue
- Editorials
- News
- Bioentrepreneur
- Opinion and Comment
- Features
- News and Views
- Computational Biology
- Research
- Naturejobs
Editorials
US biodefense—shocking and awful - p603
doi:10.1038/nbt0607-603
Abstract - US biodefense[mdash]shocking and awful | Full Text - US biodefense—shocking and awful | PDF (110 KB) - US biodefense—shocking and awful
Superscience me! - p604
doi:10.1038/nbt0607-604
Abstract - Superscience me! | Full Text - Superscience me! | PDF (49 KB) - Superscience me!
News
Australia tackles bird flu using RNAi - pp605 - 606
Graeme O'Neill
doi:10.1038/nbt0607-605
Abstract - Australia tackles bird flu using RNAi | Full Text - Australia tackles bird flu using RNAi | PDF (117 KB) - Australia tackles bird flu using RNAi
FDA likely to further restrict erythropoietin use for cancer patients - pp607 - 608
Jeffrey L. Fox
doi:10.1038/nbt0607-607
Abstract - FDA likely to further restrict erythropoietin use for cancer patients | Full Text - FDA likely to further restrict erythropoietin use for cancer patients | PDF (101 KB) - FDA likely to further restrict erythropoietin use for cancer patients
Licensing deals morph to acquisitions in seller's market - pp609 - 610
Nuala Moran
doi:10.1038/nbt0607-609
Abstract - Licensing deals morph to acquisitions in seller's market | Full Text - Licensing deals morph to acquisitions in seller's market | PDF (282 KB) - Licensing deals morph to acquisitions in seller's market
User-fee bill passes US Senate, but legislative hurdles remain - p611
Jeffrey L. Fox
doi:10.1038/nbt0607-611
Abstract - User-fee bill passes US Senate, but legislative hurdles remain | Full Text - User-fee bill passes US Senate, but legislative hurdles remain | PDF (121 KB) - User-fee bill passes US Senate, but legislative hurdles remain
In Brief
News in brief - pp613 - 614
doi:10.1038/nbt0607-613
Profile
Profile: Alfred E. Mann - p615
Ann Roberts Brice
doi:10.1038/nbt0607-615
Abstract - Profile: Alfred E. Mann | Full Text - Profile: Alfred E. Mann | PDF (249 KB) - Profile: Alfred E. Mann
Data Page
Tech transfer fails to translate into startups - p616
Stacy Lawrence
doi:10.1038/nbt0607-616
Full Text - Tech transfer fails to translate into startups | PDF (126 KB) - Tech transfer fails to translate into startups
News Feature
Biotech at the beauty counter - pp617 - 619
Barbara Nasto
doi:10.1038/nbt0607-617
Abstract - Biotech at the beauty counter | Full Text - Biotech at the beauty counter | PDF (152 KB) - Biotech at the beauty counter
Bioentrepreneur
Building a business
Planning your taxes in the UK - pp621 - 622
Joanne Brien & Helen Forker
doi:10.1038/bioent919
Opinion and Comment
Correspondence
What we know and don't know about Golden Rice - p623
Michael B Krawinkel
doi:10.1038/nbt0607-623
Full Text - What we know and don't know about Golden Rice | PDF (117 KB) - What we know and don't know about Golden Rice
What we know and don't know about Golden Rice - p624
doi:10.1038/nbt0607-624a
Full Text - What we know and don't know about Golden Rice | PDF (109 KB) - What we know and don't know about Golden Rice
Trends in GM crop, food and feed safety literature - pp624 - 626
Philippe Vain
doi:10.1038/nbt0607-624b
Full Text - Trends in GM crop, food and feed safety literature | PDF (155 KB) - Trends in GM crop, food and feed safety literature | Supplementary information
Commentary
DNA synthesis and biological security - pp627 - 629
Hans Bügl, John P Danner, Robert J Molinari, John T Mulligan, Han-Oh Park, Bas Reichert, David A Roth, Ralf Wagner, Bruce Budowle, Robert M Scripp, Jenifer A L Smith, Scott J Steele, George Church & Drew Endy
doi:10.1038/nbt0607-627
Abstract - DNA synthesis and biological security | Full Text - DNA synthesis and biological security | PDF (167 KB) - DNA synthesis and biological security
Features
MicroRNA gets down to business - pp631 - 638
George S Mack
doi:10.1038/nbt0607-631
Abstract - MicroRNA gets down to business | Full Text - MicroRNA gets down to business | PDF (736 KB) - MicroRNA gets down to business
Patents
Time waits for no man: deciding when to file a patent application in Europe - pp639 - 641
Nina L White
doi:10.1038/nbt0607-639
Abstract - Time waits for no man: deciding when to file a patent application in Europe | Full Text - Time waits for no man: deciding when to file a patent application in Europe | PDF (92 KB) - Time waits for no man: deciding when to file a patent application in Europe
Recent patent applications in DNA synthesis - p642
doi:10.1038/nbt0607-642
Full Text - Recent patent applications in DNA synthesis | PDF (39 KB) - Recent patent applications in DNA synthesis
News and Views
Assisted suicide for retroviruses - pp643 - 644
Welkin E Johnson
doi:10.1038/nbt0607-643
Abstract - Assisted suicide for retroviruses | Full Text - Assisted suicide for retroviruses | PDF (107 KB) - Assisted suicide for retroviruses
See also: Research by Matzen et al.
A green light to expression in time and space - pp645 - 646
Susan E Mango
doi:10.1038/nbt0607-645
Abstract - A green light to expression in time and space | Full Text - A green light to expression in time and space | PDF (188 KB) - A green light to expression in time and space
See also: Research by Dupuy et al.
Membrane proteins up for grabs - pp646 - 647
Gunnar von Heijne
doi:10.1038/nbt0607-646
Abstract - Membrane proteins up for grabs | Full Text - Membrane proteins up for grabs | PDF (118 KB) - Membrane proteins up for grabs
Research highlights - p649
doi:10.1038/nbt0607-649
Full Text - Research highlights | PDF (76 KB) - Research highlights
Computational Biology
Analysis
Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs - pp651 - 655
Jan Eriksson & David Fenyö
doi:10.1038/nbt1315
Abstract - Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs | Full Text - Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs | PDF (463 KB) - Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs | Supplementary information
Research
Brief Communications
Improved antimicrobial peptides based on acyl-lysine oligomers - pp657 - 659
Inna S Radzishevsky, Shahar Rotem, Dmitry Bourdetsky, Shiri Navon-Venezia, Yehuda Carmeli & Amram Mor
doi:10.1038/nbt1309
First paragraph - Improved antimicrobial peptides based on acyl-lysine oligomers | Full Text - Improved antimicrobial peptides based on acyl-lysine oligomers | PDF (173 KB) - Improved antimicrobial peptides based on acyl-lysine oligomers | Supplementary information
Engineering synthetic signaling proteins with ultrasensitive input/output control - pp660 - 662
John E Dueber, Ethan A Mirsky & Wendell A Lim
doi:10.1038/nbt1308
First paragraph - Engineering synthetic signaling proteins with ultrasensitive input/output control | Full Text - Engineering synthetic signaling proteins with ultrasensitive input/output control | PDF (209 KB) - Engineering synthetic signaling proteins with ultrasensitive input/output control | Supplementary information
Article
Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans - pp663 - 668
Denis Dupuy, Nicolas Bertin, César A Hidalgo, Kavitha Venkatesan, Domena Tu, David Lee, Jennifer Rosenberg, Nenad Svrzikapa, Aurélie Blanc, Alain Carnec, Anne-Ruxandra Carvunis, Rock Pulak, Jane Shingles, John Reece-Hoyes, Rebecca Hunt-Newbury, Ryan Viveiros, William A Mohler, Murat Tasan, Frederick P Roth, Christian Le Peuch, Ian A Hope, Robert Johnsen, Donald G Moerman, Albert-László Barabási, David Baillie & Marc Vidal
doi:10.1038/nbt1305
Abstract - Genome-scale analysis of : in vivo: spatiotemporal promoter activity in : Caenorhabditis elegans | Full Text - Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans | PDF (526 KB) - Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans | Supplementary information
See also: News and Views by Mango
Letters
RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides - pp669 - 674
Kathrin Matzen, Lina Elzaouk, Alexey A Matskevich, Anja Nitzsche, Jochen Heinrich & Karin Moelling
doi:10.1038/nbt1311
Abstract - RNase H: -mediated retrovirus destruction : in vivo: triggered by oligodeoxynucleotides | Full Text - RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides | PDF (258 KB) - RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides
See also: News and Views by Johnson
Decoding global gene expression programs in liver cancer by noninvasive imaging - pp675 - 680
Eran Segal, Claude B Sirlin, Clara Ooi, Adam S Adler, Jeremy Gollub, Xin Chen, Bryan K Chan, George R Matcuk, Christopher T Barry, Howard Y Chang & Michael D Kuo
doi:10.1038/nbt1306
First paragraph - Decoding global gene expression programs in liver cancer by noninvasive imaging | Full Text - Decoding global gene expression programs in liver cancer by noninvasive imaging | PDF (412 KB) - Decoding global gene expression programs in liver cancer by noninvasive imaging | Supplementary information
A ROCK inhibitor permits survival of dissociated human embryonic stem cells - pp681 - 686
Kiichi Watanabe, Morio Ueno, Daisuke Kamiya, Ayaka Nishiyama, Michiru Matsumura, Takafumi Wataya, Jun B Takahashi, Satomi Nishikawa, Shin-ichi Nishikawa, Keiko Muguruma & Yoshiki Sasai
doi:10.1038/nbt1310
First paragraph - A ROCK inhibitor permits survival of dissociated human embryonic stem cells | Full Text - A ROCK inhibitor permits survival of dissociated human embryonic stem cells | PDF (534 KB) - A ROCK inhibitor permits survival of dissociated human embryonic stem cells | Supplementary information
Erratum
Erratum: Billion dollar babies—biotech drugs as blockbusters - p687
Stacy Lawrence
doi:10.1038/nbt0607-687a
Full Text - Erratum: Billion dollar babies—biotech drugs as blockbusters | PDF (50 KB) - Erratum: Billion dollar babies—biotech drugs as blockbusters
Corrigenda
Corrigendum: Toll-free vaccines? - p687
Arthur M Krieg
doi:10.1038/nbt0607-687b
Full Text - Corrigendum: Toll-free vaccines? | PDF (50 KB) - Corrigendum: Toll-free vaccines?
Addendum
Addendum: Response to "Blame factory farming, not organic food" - p687
doi:10.1038/nbt0607-687c
Full Text - Addendum: Response to "Blame factory farming, not organic food" | PDF (50 KB) - Addendum: Response to "Blame factory farming, not organic food"
Naturejobs
Careers and Recruitment
Managing change in biotech: mergers and acquisitions - p689
Mary Ann Rafferty
doi:10.1038/nbt0607-689
Abstract - Managing change in biotech: mergers and acquisitions | Full Text - Managing change in biotech: mergers and acquisitions | PDF (528 KB) - Managing change in biotech: mergers and acquisitions


